Literature DB >> 14633261

Current status of immunoprophylaxis with anti-D immunoglobin.

C P Engelfriet, H W Reesink, W J Judd, V-M Ulander, M Kuosmanen, S Koskinen, P Rouger, F Morelati, V Tantalo, T Fujii, M de Haas, C E van der Schoot, M Overbeeke, J Koelewijn, G Bonsel, T Vrijkotte, B Zupańska, C Martin-Vega, R Parra Lopez, M de Silva, M Contreras, S Panzer, B Ulm, W R Mayr.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 14633261     DOI： 10.1111/j.0042-9007.2003.364_1.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN： 0042-9007            Impact factor:   2.144


× No keyword cloud information.
  11 in total

Review 1.  Molecular genetics and clinical applications for RH.

Authors:  Willy A Flegel
Journal:  Transfus Apher Sci       Date:  2011-01-28       Impact factor: 1.764

2.  Implementing non-invasive RHD genotyping on cell-free foetal DNA from maternal plasma: the Pavia experience.

Authors:  Ilaria Sbarsi; Paola Isernia; Laura Montanari; Carla Badulli; Miryam Martinetti; Laura Salvaneschi
Journal:  Blood Transfus       Date:  2011-11-16       Impact factor: 3.443

3.  A survey of the current use of anti-D immunoprophylaxis and the incidence of haemolytic disease of the newborn in Italy.

Authors:  Claudio Velati
Journal:  Blood Transfus       Date:  2007-01       Impact factor: 3.443

4.  Forty years of anti-D immunoprophylaxis.

Authors:  Giorgio Reali
Journal:  Blood Transfus       Date:  2007-01       Impact factor: 3.443

5.  Experience in the evaluation of foeto-maternal haemorrhage by flow cytometry.

Authors:  Pier Luigi Tazzari; Francesca Ricci; Silvia Manfroi; Pasqualepaolo Pagliaro
Journal:  Blood Transfus       Date:  2012-10-10       Impact factor: 3.443

6.  The importance of antenatal prevention of RhD immunisation in the first pregnancy.

Authors:  Slavica Dajak; Damir Roje; Željka Hundrić Hašpl; Pera Erceg Maglić
Journal:  Blood Transfus       Date:  2014-01-02       Impact factor: 3.443

7.  Reliable Determination of Fetal RhD Status by RHD Genotyping from Maternal Plasma.

Authors:  Tadeja Dovč-Drnovšek; Polona Klemenc; Nataša Toplak; Tanja Blejec; Irena Bricl; Primož Rožman
Journal:  Transfus Med Hemother       Date:  2013-01-03       Impact factor: 3.747

8.  Constructing a population-based research database from routine maternal screening records: a resource for studying alloimmunization in pregnant women.

Authors:  Brian K Lee; Alexander Ploner; Zhongxing Zhang; Gunilla Gryfelt; Agneta Wikman; Marie Reilly
Journal:  PLoS One       Date:  2011-11-30       Impact factor: 3.240

9.  Risk factors for RhD immunisation despite antenatal and postnatal anti-D prophylaxis.

Authors:  J M Koelewijn; M de Haas; T G M Vrijkotte; C E van der Schoot; G J Bonsel
Journal:  BJOG       Date:  2009-06-17       Impact factor: 6.531

Review 10.  Anti-D administration in pregnancy for preventing Rhesus alloimmunisation.

Authors:  Rosemary D McBain; Caroline A Crowther; Philippa Middleton
Journal:  Cochrane Database Syst Rev       Date:  2015-09-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.